Roivant Sciences (ROIV) is up 12.0%, or $1.70 to $15.88.
Easter Sale - 70% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ROIV:
- Roivant Sciences Announces Positive Phase 3 Study Results
- Roivant, Priovant reports Phase 3 VALOR study results for brepocitinib
- Roivant Sciences Approves Proposals at Annual Meeting
- Promising Pipeline and Strategic Positioning of Roivant Sciences: A Buy Recommendation with a $16 Price Target by 2025
- Pulmovant receives orphan drug designation from Japan MHLW for mosliciguat